Companies / Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
RETACIK 1358762
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | Soni Manmeet Singh Executive | Sell Open-market sale | Class A common stock | $12.35M | -75K -53.81% | 64,376 | medium |
| Jul 28, 2023 | Bir Dawn Carter Executive | Sell Open-market sale | Class A common stock | $6.58M | -40K -53.33% | 35,010 | medium |
| Mar 6, 2023 | Bir Dawn Carter Executive | Sell Open-market sale | Class A common stock | $3.58M | -40K -41.43% | 56,745 | medium |
| Mar 7, 2023 | Bir Dawn Carter Executive | Sell Open-market sale | Class A common stock | $3.07M | -36K -43.14% | 47,506 | medium |
| Mar 2, 2023 | Meyer Colin John Executive | Sell Open-market sale | Class A common stock | $3.01M | -35K -22.25% | 121,603 | medium |
| Jun 13, 2023 | Soni Manmeet Singh Executive | Sell Open-market sale | Class A common stock | $2.66M | -26K -26.01% | 72,642 | medium |
| Mar 2, 2023 | Meyer Colin John Executive | Sell Open-market sale | Class A common stock | $1.94M | -23K -12.70% | 156,397 | medium |
| Jun 14, 2021 | Meyer Colin John Executive | Sell Open-market sale | Class A common stock | $1.81M | -13K -16.38% | 64,385 | medium |